Covid-19 Impact on Global Overactive Bladder Treatment Market Size, Status and Forecast 2020-2026

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).

In 2018, USA accounts for 61% of the overactive bladder treatment market.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Overactive Bladder Treatment market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Overactive Bladder Treatment industry.

Based on our recent survey, we have several different scenarios about the Overactive Bladder Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 5263.5 million in 2019. The market size of Overactive Bladder Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Overactive Bladder Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Overactive Bladder Treatment market in terms of revenue.

Players, stakeholders, and other participants in the global Overactive Bladder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Overactive Bladder Treatment market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Overactive Bladder Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Overactive Bladder Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Overactive Bladder Treatment market.

The following players are covered in this report:

    Allergan

    Astellas Pharma

    Pfizer

    Johnson & Johnson

    Medtronic

    KYORIN Pharmaceutical

    ...

    Drugs

    Device

    Drug segment dominated the market with share about 98.5%.

    Idiopathic Overactive Bladder

    Neurogenic Overactive Bladder

    The idiopathic overactive bladder holds an important share in terms of applications, and accounts for 80% of the market share.

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Overactive Bladder Treatment Revenue

1.4 Market Analysis by Type

1.4.1 Global Overactive Bladder Treatment Market Size Growth Rate by Type: 2020 VS 2026

1.4.2 Drugs

1.4.3 Device

1.5 Market by Application

1.5.1 Global Overactive Bladder Treatment Market Share by Application: 2020 VS 2026

1.5.2 Idiopathic Overactive Bladder

1.5.3 Neurogenic Overactive Bladder

1.6 Coronavirus Disease 2019 (Covid-19): Overactive Bladder Treatment Industry Impact

1.6.1 How the Covid-19 is Affecting the Overactive Bladder Treatment Industry

1.6.1.1 Overactive Bladder Treatment Business Impact Assessment - Covid-19

1.6.1.2 Supply Chain Challenges

1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products

1.6.2 Market Trends and Overactive Bladder Treatment Potential Opportunities in the COVID-19 Landscape

1.6.3 Measures / Proposal against Covid-19

1.6.3.1 Government Measures to Combat Covid-19 Impact

1.6.3.2 Proposal for Overactive Bladder Treatment Players to Combat Covid-19 Impact

1.7 Study Objectives

1.8 Years Considered

2.1 Overactive Bladder Treatment Market Perspective (2015-2026)

2.2 Overactive Bladder Treatment Growth Trends by Regions

2.2.1 Overactive Bladder Treatment Market Size by Regions: 2015 VS 2020 VS 2026

2.2.2 Overactive Bladder Treatment Historic Market Share by Regions (2015-2020)

2.2.3 Overactive Bladder Treatment Forecasted Market Size by Regions (2021-2026)

2.3 Industry Trends and Growth Strategy

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Challenges

2.3.4 Porter’s Five Forces Analysis

2.3.5 Overactive Bladder Treatment Market Growth Strategy

2.3.6 Primary Interviews with Key Overactive Bladder Treatment Players (Opinion Leaders)

3.1 Global Top Overactive Bladder Treatment Players by Market Size

3.1.1 Global Top Overactive Bladder Treatment Players by Revenue (2015-2020)

3.1.2 Global Overactive Bladder Treatment Revenue Market Share by Players (2015-2020)

3.1.3 Global Overactive Bladder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.2 Global Overactive Bladder Treatment Market Concentration Ratio

3.2.1 Global Overactive Bladder Treatment Market Concentration Ratio (CR5 and HHI)

3.2.2 Global Top 10 and Top 5 Companies by Overactive Bladder Treatment Revenue in 2019

3.3 Overactive Bladder Treatment Key Players Head office and Area Served

3.4 Key Players Overactive Bladder Treatment Product Solution and Service

3.5 Date of Enter into Overactive Bladder Treatment Market

3.6 Mergers & Acquisitions, Expansion Plans

4.1 Global Overactive Bladder Treatment Historic Market Size by Type (2015-2020)

4.2 Global Overactive Bladder Treatment Forecasted Market Size by Type (2021-2026)

5.1 Global Overactive Bladder Treatment Market Size by Application (2015-2020)

5.2 Global Overactive Bladder Treatment Forecasted Market Size by Application (2021-2026)

6.1 North America Overactive Bladder Treatment Market Size (2015-2020)

6.2 Overactive Bladder Treatment Key Players in North America (2019-2020)

6.3 North America Overactive Bladder Treatment Market Size by Type (2015-2020)

6.4 North America Overactive Bladder Treatment Market Size by Application (2015-2020)

7.1 Europe Overactive Bladder Treatment Market Size (2015-2020)

7.2 Overactive Bladder Treatment Key Players in Europe (2019-2020)

7.3 Europe Overactive Bladder Treatment Market Size by Type (2015-2020)

7.4 Europe Overactive Bladder Treatment Market Size by Application (2015-2020)

8.1 China Overactive Bladder Treatment Market Size (2015-2020)

8.2 Overactive Bladder Treatment Key Players in China (2019-2020)

8.3 China Overactive Bladder Treatment Market Size by Type (2015-2020)

8.4 China Overactive Bladder Treatment Market Size by Application (2015-2020)

9.1 Japan Overactive Bladder Treatment Market Size (2015-2020)

9.2 Overactive Bladder Treatment Key Players in Japan (2019-2020)

9.3 Japan Overactive Bladder Treatment Market Size by Type (2015-2020)

9.4 Japan Overactive Bladder Treatment Market Size by Application (2015-2020)

10.1 Southeast Asia Overactive Bladder Treatment Market Size (2015-2020)

10.2 Overactive Bladder Treatment Key Players in Southeast Asia (2019-2020)

10.3 Southeast Asia Overactive Bladder Treatment Market Size by Type (2015-2020)

10.4 Southeast Asia Overactive Bladder Treatment Market Size by Application (2015-2020)

11.1 India Overactive Bladder Treatment Market Size (2015-2020)

11.2 Overactive Bladder Treatment Key Players in India (2019-2020)

11.3 India Overactive Bladder Treatment Market Size by Type (2015-2020)

11.4 India Overactive Bladder Treatment Market Size by Application (2015-2020)

12.1 Central & South America Overactive Bladder Treatment Market Size (2015-2020)

12.2 Overactive Bladder Treatment Key Players in Central & South America (2019-2020)

12.3 Central & South America Overactive Bladder Treatment Market Size by Type (2015-2020)

12.4 Central & South America Overactive Bladder Treatment Market Size by Application (2015-2020)

13.1 Allergan

13.1.1 Allergan Company Details

13.1.2 Allergan Business Overview and Its Total Revenue

13.1.3 Allergan Overactive Bladder Treatment Introduction

13.1.4 Allergan Revenue in Overactive Bladder Treatment Business (2015-2020))

13.1.5 Allergan Recent Development

13.2 Astellas Pharma

13.2.1 Astellas Pharma Company Details

13.2.2 Astellas Pharma Business Overview and Its Total Revenue

13.2.3 Astellas Pharma Overactive Bladder Treatment Introduction

13.2.4 Astellas Pharma Revenue in Overactive Bladder Treatment Business (2015-2020)

13.2.5 Astellas Pharma Recent Development

13.3 Pfizer

13.3.1 Pfizer Company Details

13.3.2 Pfizer Business Overview and Its Total Revenue

13.3.3 Pfizer Overactive Bladder Treatment Introduction

13.3.4 Pfizer Revenue in Overactive Bladder Treatment Business (2015-2020)

13.3.5 Pfizer Recent Development

13.4 Johnson & Johnson

13.4.1 Johnson & Johnson Company Details

13.4.2 Johnson & Johnson Business Overview and Its Total Revenue

13.4.3 Johnson & Johnson Overactive Bladder Treatment Introduction

13.4.4 Johnson & Johnson Revenue in Overactive Bladder Treatment Business (2015-2020)

13.4.5 Johnson & Johnson Recent Development

13.5 Medtronic

13.5.1 Medtronic Company Details

13.5.2 Medtronic Business Overview and Its Total Revenue

13.5.3 Medtronic Overactive Bladder Treatment Introduction

13.5.4 Medtronic Revenue in Overactive Bladder Treatment Business (2015-2020)

13.5.5 Medtronic Recent Development

13.6 KYORIN Pharmaceutical

13.6.1 KYORIN Pharmaceutical Company Details

13.6.2 KYORIN Pharmaceutical Business Overview and Its Total Revenue

13.6.3 KYORIN Pharmaceutical Overactive Bladder Treatment Introduction

13.6.4 KYORIN Pharmaceutical Revenue in Overactive Bladder Treatment Business (2015-2020)

13.6.5 KYORIN Pharmaceutical Recent Development

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Disclaimer

15.3 Author Details

List of Tables

    Table 1. Overactive Bladder Treatment Key Market Segments

    Table 2. Key Players Covered: Ranking by Overactive Bladder Treatment Revenue

    Table 3. Ranking of Global Top Overactive Bladder Treatment Manufacturers by Revenue (US$ Million) in 2019

    Table 4. Global Overactive Bladder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

    Table 5. Key Players of Drugs

    Table 6. Key Players of Device

    Table 7. COVID-19 Impact Global Market: (Four Overactive Bladder Treatment Market Size Forecast Scenarios)

    Table 8. Opportunities and Trends for Overactive Bladder Treatment Players in the COVID-19 Landscape

    Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

    Table 10. Key Regions/Countries Measures against Covid-19 Impact

    Table 11. Proposal for Overactive Bladder Treatment Players to Combat Covid-19 Impact

    Table 12. Global Overactive Bladder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026

    Table 13. Global Overactive Bladder Treatment Market Size by Regions (US$ Million): 2020 VS 2026

    Table 14. Global Overactive Bladder Treatment Market Size by Regions (2015-2020) (US$ Million)

    Table 15. Global Overactive Bladder Treatment Market Share by Regions (2015-2020)

    Table 16. Global Overactive Bladder Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)

    Table 17. Global Overactive Bladder Treatment Market Share by Regions (2021-2026)

    Table 18. Market Top Trends

    Table 19. Key Drivers: Impact Analysis

    Table 20. Key Challenges

    Table 21. Overactive Bladder Treatment Market Growth Strategy

    Table 22. Main Points Interviewed from Key Overactive Bladder Treatment Players

    Table 23. Global Overactive Bladder Treatment Revenue by Players (2015-2020) (Million US$)

    Table 24. Global Overactive Bladder Treatment Market Share by Players (2015-2020)

    Table 25. Global Top Overactive Bladder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Overactive Bladder Treatment as of 2019)

    Table 26. Global Overactive Bladder Treatment by Players Market Concentration Ratio (CR5 and HHI)

    Table 27. Key Players Headquarters and Area Served

    Table 28. Key Players Overactive Bladder Treatment Product Solution and Service

    Table 29. Date of Enter into Overactive Bladder Treatment Market

    Table 30. Mergers & Acquisitions, Expansion Plans

    Table 31. Global Overactive Bladder Treatment Market Size by Type (2015-2020) (Million US$)

    Table 32. Global Overactive Bladder Treatment Market Size Share by Type (2015-2020)

    Table 33. Global Overactive Bladder Treatment Revenue Market Share by Type (2021-2026)

    Table 34. Global Overactive Bladder Treatment Market Size Share by Application (2015-2020)

    Table 35. Global Overactive Bladder Treatment Market Size by Application (2015-2020) (Million US$)

    Table 36. Global Overactive Bladder Treatment Market Size Share by Application (2021-2026)

    Table 37. North America Key Players Overactive Bladder Treatment Revenue (2019-2020) (Million US$)

    Table 38. North America Key Players Overactive Bladder Treatment Market Share (2019-2020)

    Table 39. North America Overactive Bladder Treatment Market Size by Type (2015-2020) (Million US$)

    Table 40. North America Overactive Bladder Treatment Market Share by Type (2015-2020)

    Table 41. North America Overactive Bladder Treatment Market Size by Application (2015-2020) (Million US$)

    Table 42. North America Overactive Bladder Treatment Market Share by Application (2015-2020)

    Table 43. Europe Key Players Overactive Bladder Treatment Revenue (2019-2020) (Million US$)

    Table 44. Europe Key Players Overactive Bladder Treatment Market Share (2019-2020)

    Table 45. Europe Overactive Bladder Treatment Market Size by Type (2015-2020) (Million US$)

    Table 46. Europe Overactive Bladder Treatment Market Share by Type (2015-2020)

    Table 47. Europe Overactive Bladder Treatment Market Size by Application (2015-2020) (Million US$)

    Table 48. Europe Overactive Bladder Treatment Market Share by Application (2015-2020)

    Table 49. China Key Players Overactive Bladder Treatment Revenue (2019-2020) (Million US$)

    Table 50. China Key Players Overactive Bladder Treatment Market Share (2019-2020)

    Table 51. China Overactive Bladder Treatment Market Size by Type (2015-2020) (Million US$)

    Table 52. China Overactive Bladder Treatment Market Share by Type (2015-2020)

    Table 53. China Overactive Bladder Treatment Market Size by Application (2015-2020) (Million US$)

    Table 54. China Overactive Bladder Treatment Market Share by Application (2015-2020)

    Table 55. Japan Key Players Overactive Bladder Treatment Revenue (2019-2020) (Million US$)

    Table 56. Japan Key Players Overactive Bladder Treatment Market Share (2019-2020)

    Table 57. Japan Overactive Bladder Treatment Market Size by Type (2015-2020) (Million US$)

    Table 58. Japan Overactive Bladder Treatment Market Share by Type (2015-2020)

    Table 59. Japan Overactive Bladder Treatment Market Size by Application (2015-2020) (Million US$)

    Table 60. Japan Overactive Bladder Treatment Market Share by Application (2015-2020)

    Table 61. Southeast Asia Key Players Overactive Bladder Treatment Revenue (2019-2020) (Million US$)

    Table 62. Southeast Asia Key Players Overactive Bladder Treatment Market Share (2019-2020)

    Table 63. Southeast Asia Overactive Bladder Treatment Market Size by Type (2015-2020) (Million US$)

    Table 64. Southeast Asia Overactive Bladder Treatment Market Share by Type (2015-2020)

    Table 65. Southeast Asia Overactive Bladder Treatment Market Size by Application (2015-2020) (Million US$)

    Table 66. Southeast Asia Overactive Bladder Treatment Market Share by Application (2015-2020)

    Table 67. India Key Players Overactive Bladder Treatment Revenue (2019-2020) (Million US$)

    Table 68. India Key Players Overactive Bladder Treatment Market Share (2019-2020)

    Table 69. India Overactive Bladder Treatment Market Size by Type (2015-2020) (Million US$)

    Table 70. India Overactive Bladder Treatment Market Share by Type (2015-2020)

    Table 71. India Overactive Bladder Treatment Market Size by Application (2015-2020) (Million US$)

    Table 72. India Overactive Bladder Treatment Market Share by Application (2015-2020)

    Table 73. Central & South America Key Players Overactive Bladder Treatment Revenue (2019-2020) (Million US$)

    Table 74. Central & South America Key Players Overactive Bladder Treatment Market Share (2019-2020)

    Table 75. Central & South America Overactive Bladder Treatment Market Size by Type (2015-2020) (Million US$)

    Table 76. Central & South America Overactive Bladder Treatment Market Share by Type (2015-2020)

    Table 77. Central & South America Overactive Bladder Treatment Market Size by Application (2015-2020) (Million US$)

    Table 78. Central & South America Overactive Bladder Treatment Market Share by Application (2015-2020)

    Table 79. Allergan Company Details

    Table 80. Allergan Business Overview

    Table 81. Allergan Product

    Table 82. Allergan Revenue in Overactive Bladder Treatment Business (2015-2020) (Million US$)

    Table 83. Allergan Recent Development

    Table 84. Astellas Pharma Company Details

    Table 85. Astellas Pharma Business Overview

    Table 86. Astellas Pharma Product

    Table 87. Astellas Pharma Revenue in Overactive Bladder Treatment Business (2015-2020) (Million US$)

    Table 88. Astellas Pharma Recent Development

    Table 89. Pfizer Company Details

    Table 90. Pfizer Business Overview

    Table 91. Pfizer Product

    Table 92. Pfizer Revenue in Overactive Bladder Treatment Business (2015-2020) (Million US$)

    Table 93. Pfizer Recent Development

    Table 94. Johnson & Johnson Company Details

    Table 95. Johnson & Johnson Business Overview

    Table 96. Johnson & Johnson Product

    Table 97. Johnson & Johnson Revenue in Overactive Bladder Treatment Business (2015-2020) (Million US$)

    Table 98. Johnson & Johnson Recent Development

    Table 99. Medtronic Company Details

    Table 100. Medtronic Business Overview

    Table 101. Medtronic Product

    Table 102. Medtronic Revenue in Overactive Bladder Treatment Business (2015-2020) (Million US$)

    Table 103. Medtronic Recent Development

    Table 104. KYORIN Pharmaceutical Company Details

    Table 105. KYORIN Pharmaceutical Business Overview

    Table 106. KYORIN Pharmaceutical Product

    Table 107. KYORIN Pharmaceutical Revenue in Overactive Bladder Treatment Business (2015-2020) (Million US$)

    Table 108. KYORIN Pharmaceutical Recent Development

    Table 109. Research Programs/Design for This Report

    Table 110. Key Data Information from Secondary Sources

    Table 111. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Overactive Bladder Treatment Market Share by Type: 2020 VS 2026

    Figure 2. Drugs Features

    Figure 3. Device Features

    Figure 4. Global Overactive Bladder Treatment Market Share by Application: 2020 VS 2026

    Figure 5. Idiopathic Overactive Bladder Case Studies

    Figure 6. Neurogenic Overactive Bladder Case Studies

    Figure 7. Overactive Bladder Treatment Report Years Considered

    Figure 8. Global Overactive Bladder Treatment Market Size YoY Growth 2015-2026 (US$ Million)

    Figure 9. Global Overactive Bladder Treatment Market Share by Regions: 2020 VS 2026

    Figure 10. Global Overactive Bladder Treatment Market Share by Regions (2021-2026)

    Figure 11. Porter's Five Forces Analysis

    Figure 12. Global Overactive Bladder Treatment Market Share by Players in 2019

    Figure 13. Global Top Overactive Bladder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Overactive Bladder Treatment as of 2019

    Figure 14. The Top 10 and 5 Players Market Share by Overactive Bladder Treatment Revenue in 2019

    Figure 15. North America Overactive Bladder Treatment Market Size YoY Growth (2015-2020) (Million US$)

    Figure 16. Europe Overactive Bladder Treatment Market Size YoY Growth (2015-2020) (Million US$)

    Figure 17. China Overactive Bladder Treatment Market Size YoY Growth (2015-2020) (Million US$)

    Figure 18. Japan Overactive Bladder Treatment Market Size YoY Growth (2015-2020) (Million US$)

    Figure 19. Southeast Asia Overactive Bladder Treatment Market Size YoY Growth (2015-2020) (Million US$)

    Figure 20. India Overactive Bladder Treatment Market Size YoY Growth (2015-2020) (Million US$)

    Figure 21. Central & South America Overactive Bladder Treatment Market Size YoY Growth (2015-2020) (Million US$)

    Figure 22. Allergan Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 23. Allergan Revenue Growth Rate in Overactive Bladder Treatment Business (2015-2020)

    Figure 24. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 25. Astellas Pharma Revenue Growth Rate in Overactive Bladder Treatment Business (2015-2020)

    Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 27. Pfizer Revenue Growth Rate in Overactive Bladder Treatment Business (2015-2020)

    Figure 28. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 29. Johnson & Johnson Revenue Growth Rate in Overactive Bladder Treatment Business (2015-2020)

    Figure 30. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 31. Medtronic Revenue Growth Rate in Overactive Bladder Treatment Business (2015-2020)

    Figure 32. KYORIN Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 33. KYORIN Pharmaceutical Revenue Growth Rate in Overactive Bladder Treatment Business (2015-2020)

    Figure 34. Bottom-up and Top-down Approaches for This Report

    Figure 35. Data Triangulation

    Figure 36. Key Executives Interviewed